Back to News
Press Release September 24, 2020

NEWS & EVENTS

News Image

Paris, September 25 . 2020.Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announced today the appointment of Delphine Joyeux as Director of Regulatory Affairs and Quality Assurance and Simon Lambden as Head of Medical Science.


Read full article